The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
Current Oncology | Free Full-Text | Immune Checkpoint Inhibitors in Cancer Therapy
Do Checkpoint Inhibitors Increase Rejection Risk? - Division of Nephrology
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation | Journal of Medicinal Chemistry
PD-1/PD-L1 inhibitor 1 | Cas# 1675201-83-8 - GlpBio
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
PD-1 and PD-L1 inhibitors - Wikipedia
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy - ScienceDirect
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors
Immune Checkpoint Inhibitors - NCI
A PD 1 Inhibitor Fairy Tale - YouTube
Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms - Annals of Oncology
Immune checkpoint blockade in HIV - eBioMedicine
In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
PD-1/PD-L1 inhibitor 2(BMS-202)_ImmunoWay Biotechnology Company |抗体|病理抗体|诊断抗体
Current issues and perspectives in PD-1 blockade cancer immunotherapy | SpringerLink
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker - Wang - 2020 - Cancer Medicine - Wiley Online Library
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
IMMUNTERAPI
